The National Cancer Institute has a new leader: Dr. John Niederhuber,
who became its acting director June 11.
|Dr. John Niederhuber became acting director
of the National Cancer Institute on June 11.
Dr. Andrew von Eschenbach, NCI director since 2002, resigned his
position effective June 10. He will continue to serve as acting
commissioner of the Food and Drug Administration and as a senior
adviser to HHS Secretary Michael Leavitt.
Niederhuber, who joined NCI last September as deputy director
for translational and clinical sciences, has longstanding ties
to the institute across a four-decade career as a cancer surgeon
and researcher. He has been an outside adviser, grant reviewer
and, from 2002 to 2005, chair of the National Cancer Advisory Board.
Niederhuber's academic career includes service as director of
the University of Wisconsin Comprehensive Cancer Center and as
a professor at Stanford University, Johns Hopkins University and
the University of Michigan.
In a message sent to the NCI staff just after the announcement,
he wrote: "Your professionalism and your sense of mission have
infused every lab, clinic and office at NCI, and will most certainly
make this a rewarding and exciting time for all of us."